🔎 Trials Near Me

Почетна › Карцином на јајниците › Калифорнија › Los Angeles

Клинички испитувања за Карцином на јајниците во Los Angeles, CA

50 студии за Карцином на јајниците бараат учесници на локации во и околу Los Angeles (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.

Официјален текст на студијата (англиски)

Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Се регрутираФаза 1/2
  • Research Site, Los Angeles
Возраст од 18 до 130 · Сите полови · Ажурирано 5.10.2026 · NCT05417594

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Се регрутираФаза 2/3
  • Cedars-Sinai Medical Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Се регрутираФаза 2
  • The Angeles Clinic and Research Institute - West Los Angeles Office, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
Сите возрасти · Сите полови · Ажурирано 5.10.2026 · NCT05564377

A Study of PHST001 in Advanced Solid Tumors

Се регрутираФаза 1
  • USC Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT06840886

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

Се регрутираФаза 1
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Се регрутираФаза 1/2
  • UCLA Jonsson Comprehensive Cancer Center, Los Angeles
  • USC Norris Comprehensive Cancer Center, Los Angeles
Возраст 12 и постари · Сите полови · Ажурирано 2.10.2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Се регрутираФаза 1
  • University of California - Los Angeles, Los Angeles
Возраст 19 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06586957

A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

Се регрутираФаза 2
  • Start Los Angeles /ID# 281533, Los Angeles
Возраст 18 и постари · Жени · Ажурирано 1.10.2026 · NCT07024784

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Се регрутираФаза 1
  • Research Site, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT05877599

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

Се регрутираФаза 2
  • UCLA - University of California Los Angeles Medical Center /ID# 274566, Los Angeles
Возраст 18 и постари · Жени · Ажурирано 29.9.2026 · NCT06890338

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Се регрутираФаза 2
  • Research Site, Los Angeles
Возраст од 18 до 130 · Сите полови · Ажурирано 23.9.2026 · NCT05489211

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Се регрутираФаза 3
  • UCLA Hematology/Oncology - Westwood (Building 100), Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07213804

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Се регрутираФаза 3
  • Valkyrie Clinical Trials, Los Angeles
Возраст 18 и постари · Жени · Ажурирано 15.9.2026 · NCT07214779

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

Се регрутираФаза 2
  • University of California, Los Angeles Medical Center, Los Angeles
Возраст од 18 до 99 · Жени · Ажурирано 15.9.2026 · NCT07023627

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

Се регрутираФаза 2
  • Cedars Sinai Medical Center, Los Angeles
Возраст 18 и постари · Жени · Ажурирано 14.9.2026 · NCT06787612

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Се регрутираФаза 1
  • START - Los Angeles, Los Angeles
  • Cedars Sinai, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT06293898

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Се регрутираФаза 1
  • University of Southern California, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 2.9.2026 · NCT07216105

Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer

Се регрутираФаза 1/2
  • Start Cal, Los Angeles
Возраст 18 и постари · Жени · Ажурирано 1.9.2026 · NCT07736937

Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

Се регрутираФаза 1
  • University of Southern California, Los Angeles
  • Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
  • Cedars-Sanai Medical Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 27.8.2026 · NCT06582017

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Се регрутираФаза 1/2
  • Children's Hospital Los Angeles, Los Angeles
12 Months – 30 Years · Сите полови · Ажурирано 25.8.2026 · NCT04851119

A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)

Се регрутираФаза 1
  • Valkyrie Clinical Trials, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 21.8.2026 · NCT07306559

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

Се регрутираФаза 1
  • START - Los Angeles, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 18.8.2026 · NCT07470853

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

Се регрутираФаза 1/2
  • USC/Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 17.8.2026 · NCT04895709

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

Се регрутираФаза 1/2
  • USC Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 13.8.2026 · NCT05985655

A Study of MGC026 in Participants With Advanced Solid Tumors

Се регрутираФаза 1
  • The Angeles Clinic and Research Institute, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 11.8.2026 · NCT06242470

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Се регрутира
  • Keck Medicine of USC Koreatown, Los Angeles
  • Kaiser Permanente Los Angeles Medical Center, Los Angeles
  • Los Angeles General Medical Center, Los Angeles
  • и уште 3
Возраст од 35 до 50 · Жени · Ажурирано 7.8.2026 · NCT04251052

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Се регрутираФаза 3
  • Kaiser Permanente Los Angeles Medical Center, Los Angeles
  • Kaiser Permanente West Los Angeles, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 7.8.2026 · NCT06580314

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Се регрутираФаза 1/2
  • Los Angeles Cancer Network, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 5.8.2026 · NCT06330064

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Се регрутираФаза 1
  • UCLA - Hematology/Oncology Clinical Research Unit, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 5.8.2026 · NCT07444814

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Се регрутираФаза 1/2
  • University of California Los Angeles Medical Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 4.8.2026 · NCT05579366

A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors

Се регрутираФаза 1/2
  • USC Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 30.7.2026 · NCT04657068

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

Се регрутираФаза 1
  • START Los Angeles, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 22.7.2026 · NCT07524322

Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer

Се регрутираФаза 2
  • UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Сите возрасти · Жени · Ажурирано 17.7.2026 · NCT04469764

CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer

Се регрутираФаза 1/2
  • University of Southern California, Los Angeles
  • UCLA, Los Angeles
Возраст од 18 до 75 · Жени · Ажурирано 13.7.2026 · NCT07322094

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Се регрутираФаза 1/2
  • Ellison Clinic at Saint John's, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 7.7.2026 · NCT05768139

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Се регрутираФаза 1
  • Ronald Reagan UCLA Medical Center, Los Angeles
  • The Regents of the University of California, Los Angeles
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 6.7.2026 · NCT04389632

EXoPERT EMERALD Clinical Study

Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
  • City of Hope Duarte Cancer Center, Los Angeles
Возраст 45 и постари · Сите полови · Ажурирано 1.7.2026 · NCT07186296

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

Се регрутираФаза 2
  • GSK Investigational Site, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 24.6.2026 · NCT04641247

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Се регрутираФаза 1/2
  • UCLA Medical Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 12.6.2026 · NCT06051695

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Се регрутираФаза 1
  • Start Lacn, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 10.6.2026 · NCT07517198

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Се регрутираФаза 2
  • USA06-0, Los Angeles
  • USA16-0, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 22.5.2026 · NCT06953089

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Се регрутира
  • Oncology Institute for Hope and Innovation, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 30.4.2026 · NCT05297734

Access to Genetic Testing in Underserved Patients With Cancer

Се регрутираДобредојдени се здрави волонтери
  • USC / Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 18.3.2026 · NCT06422455

First in Human Study of TORL-1-23 in Participants With Advanced Cancer

Се регрутираФаза 1
  • UCLA - JCCC Clinical Research Unit, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 13.2.2026 · NCT05103683

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Се регрутираФаза 1
  • USC - Norris Comprehensive Cancer Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 13.2.2026 · NCT06778863

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

Се регрутираФаза 2
  • UCLA - JCCC Clinical Research Unit, Los Angeles
Возраст 18 и постари · Жени · Ажурирано 23.12.2025 · NCT06690775

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

Се регрутираФаза 1/2
  • University of Southern California, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 11.12.2025 · NCT06943521

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Се регрутираФаза 1/2
  • Cedars Sinai Medical Center, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 24.9.2025 · NCT05941507

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Се регрутираФаза 1/2
  • University of California, Los Angles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 1.5.2025 · NCT04503265

Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment

Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
  • MiraKind, Los Angeles
Возраст 18 и постари · Сите полови · Ажурирано 23.1.2025 · NCT02253251

Испитувања за Карцином на јајниците во други градови

Други студии во Los Angeles

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.